======= PHLPP2 ======= == Gene Information == * **Official Symbol**: PHLPP2 * **Official Name**: PH domain and leucine rich repeat protein phosphatase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23035|23035]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6ZVD8|Q6ZVD8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PHLPP2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHLPP2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611066|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Protein phosphatase involved in regulation of Akt and PKC signaling. Mediates dephosphorylation in the C-terminal domain hydrophobic motif of members of the AGC Ser/Thr protein kinase family; specifically acts on 'Ser-473' of AKT1, 'Ser-660' of PRKCB isoform beta-II and 'Ser-657' of PRKCA. Akt regulates the balance between cell survival and apoptosis through a cascade that primarily alters the function of transcription factors that regulate pro- and antiapoptotic genes. Dephosphorylation of 'Ser- 473' of Akt triggers apoptosis and decreases cell proliferation. Also controls the phosphorylation of AKT3. Dephosphorylates STK4 on 'Thr-387' leading to STK4 activation and apoptosis (PubMed:20513427). Dephosphorylates RPS6KB1 and is involved in regulation of cap-dependent translation (PubMed:21986499). Inhibits cancer cell proliferation and may act as a tumor suppressor. Dephosphorylation of PRKCA and PRKCB leads to their destabilization and degradation. Dephosphorylates RAF1 inhibiting its kinase activity (PubMed:24530606). {ECO:0000269|PubMed:17386267, ECO:0000269|PubMed:18162466, ECO:0000269|PubMed:19079341, ECO:0000269|PubMed:20513427, ECO:0000269|PubMed:21986499, ECO:0000269|PubMed:24530606}. |LRR 4| |PP2C| |photoreceptor outer segment membrane| |negative regulation of protein kinase B signaling| |photoreceptor inner segment| |protein serine/threonine phosphatase activity| |hippocampus development| |limbic system development| |pallium development| |protein dephosphorylation| |regulation of protein kinase B signaling| |telencephalon development| |dephosphorylation| |forebrain development| |negative regulation of intracellular signal transduction| |brain development| |head development| |central nervous system development| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of response to stimulus| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15011 * **Expression level (log2 read counts)**: 5.49 {{:chemogenomics:nalm6 dist.png?nolink |}}